Catalyst Funds Management Pty LTD Edgewise Therapeutics, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 1,200 shares of EWTX stock, worth $33,360. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,200Holding current value
$33,360% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
189Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$418 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$248 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$167 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$162 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$154 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.76B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...